Home » Stocks » Scholar Rock Holding

Scholar Rock Holding Corporation (SRRK)

Stock Price: $30.02 USD 16.30 (118.80%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $34.40 +4.38 (14.59%) Oct 27, 6:28 PM

Stock Price Chart

Key Info

Market Cap 896.84M
Revenue (ttm) 21.28M
Net Income (ttm) -64.07M
Shares Out 29.87M
EPS (ttm) -2.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $30.02
Previous Close $13.72
Change ($) 16.30
Change (%) 118.80%
Day's Open 17.25
Day's Range 17.25 - 31.69
Day's Volume 52,452,483
52-Week Range 6.95 - 31.69

More Stats

Market Cap 896.84M
Enterprise Value 757.93M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 29.87M
Float 20.03M
EPS (basic) -2.17
EPS (diluted) -2.18
FCF / Share -1.70
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.85M
Short Ratio 14.88
Short % of Float 9.24%
Beta 0.68
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 42.15
PB Ratio 5.03
Revenue 21.28M
Operating Income -66.61M
Net Income -64.07M
Free Cash Flow -50.48M
Net Cash 138.91M
Net Cash / Share 4.65
Gross Margin -158.50%
Operating Margin -313.06%
Profit Margin -301.10%
FCF Margin -237.26%
ROA -23.57%
ROE -60.69%
ROIC -78.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(-5.90% downside)
Current: $30.02
Target: 28.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit20.49--0.38
Operating Income-54.54-50.69-25.03-16.21
Net Income-51.00-49.33-25.00-16.21
Shares Outstanding27.5415.661.631.60
Earnings Per Share-1.85-3.15-15.30-10.11
Operating Cash Flow-63.1224.57-21.74-15.14
Capital Expenditures-3.11-1.49-0.36-0.79
Free Cash Flow-66.2223.08-22.10-15.94
Cash & Equivalents16017658.1628.24
Total Debt5.300.421.041.67
Net Cash / Debt15517557.1326.57
Book Value113107-53.52-30.03
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Scholar Rock Holding Corporation
Country United States
Employees 93
CEO Stuart Anthony Kingsley

Stock Information

Ticker Symbol SRRK
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: SRRK
IPO Date May 24, 2018


Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, a novel inhibitor of the activation of myostatin, which is in Phase II clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1. In addition, it is developing a pipeline of novel product candidates for a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.